Adiponectin Paradox More Evident in Non-Obese Than in Obese Patients with Diabetic Microvascular Complications

References

• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625. doi:10.2337/diabetes.54.6.1615
   PubMed Web of Science ®Google Scholar
• Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986.
   PubMed Web of Science ®Google Scholar
• Man REK, Gan ATL, Fenwick EK, et al. The relationship between generalized and abdominal obesity with diabetic kidney disease in type 2 diabetes: a multiethnic asian study and meta-analysis. Nutrients. 2018;10(11):1685. doi:10.3390/nu10111685
   PubMed Web of Science ®Google Scholar
• Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53(8):2087–2094. doi:10.2337/diabetes.53.8.2087
   PubMed Web of Science ®Google Scholar
• Suzuki T, Gao J, Ishigaki Y, et al. ER stress protein CHOP mediates insulin resistance by modulating adipose tissue macrophage polarity. Cell Rep. 2017;18(8):2045–2057. doi:10.1016/j.celrep.2017.01.076
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996;97(11):2601–2610. doi:10.1172/JCI118709
   PubMed Web of Science ®Google Scholar
• Purdy JC, Shatzel JJ. The hematologic consequences of obesity. Eur J Haematol. 2021;106(3):306–319. doi:10.1111/ejh.13560
   PubMed Web of Science ®Google Scholar
• Kovesdy CP, Furth SL, Zoccali C. Obesity and kidney disease: hidden consequences of the epidemic. Am J Nephrol. 2017;45(3):283–291. doi:10.1159/000458467
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang Y, Shi K, Wang C. Body mass index and risk of diabetic retinopathy: a meta-analysis and systematic review. Medicine. 2017;96(22):e6754. doi:10.1097/MD.0000000000006754
   PubMed Web of Science ®Google Scholar
• Man RE, Sabanayagam C, Chiang PP, et al. Differential association of generalized and abdominal obesity with diabetic retinopathy in asian patients with type 2 diabetes. JAMA Ophthalmol. 2016;134(3):251–257. doi:10.1001/jamaophthalmol.2015.5103
   PubMed Web of Science ®Google Scholar
• Sampath Kumar A, Arun Maiya G, Shastry BA, Vaishali K, Maiya S, Umakanth S. Correlation between basal metabolic rate, visceral fat and insulin resistance among type 2 diabetes mellitus with peripheral neuropathy. Diabetes Metab Syndr. 2019;13(1):344–348. doi:10.1016/j.dsx.2018.10.005
   PubMed Web of Science ®Google Scholar
• Oh TJ, Lee JE, Choi SH, Jang HC. Association between body fat and diabetic peripheral neuropathy in middle-aged adults with type 2 diabetes mellitus: a preliminary report. J Obes Metab Syndr. 2019;28(2):112–117. doi:10.7570/jomes.2019.28.2.112
   PubMed Web of Science ®Google Scholar
• Matsushita Y, Hasegawa Y, Takebe N, et al. Serum C-X-C motif chemokine ligand 14 levels are associated with serum C-peptide and fatty liver index in type 2 diabetes mellitus patients. J Diabetes Investig. 2021;12(6):1042–1049. doi:10.1111/jdi.13438
   PubMed Web of Science ®Google Scholar
• Maeda N, Funahashi T, Matsuzawa Y, Shimomura I. Adiponectin, a unique adipocyte-derived factor beyond hormones. Atherosclerosis. 2020;292:1–9. doi:10.1016/j.atherosclerosis.2019.10.021
   PubMed Web of Science ®Google Scholar
• Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380(1–2):24–30. doi:10.1016/j.cca.2007.01.026
   PubMed Web of Science ®Google Scholar
• Aljafary MA, Al-Suhaimi EA. Adiponectin system (rescue hormone): the missing link between metabolic and cardiovascular diseases. Pharmaceutics. 2022;14(7):1430. doi:10.3390/pharmaceutics14071430
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24(1):29–33. doi:10.1161/01.ATV.0000099786.99623.EF
   PubMed Web of Science ®Google Scholar
• Menzaghi C, Trischitta V. The adiponectin paradox for all-cause and cardiovascular mortality. Diabetes. 2018;67(1):12–22. doi:10.2337/dbi17-0016
   PubMed Web of Science ®Google Scholar
• Rodríguez AJ, Nunes Vdos S, Mastronardi CA, Neeman T, Paz-Filho GJ. Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of controlled cross-sectional studies. J Diabetes Complications. 2016;30(2):357–367. doi:10.1016/j.jdiacomp.2015.11.004
   PubMed Web of Science ®Google Scholar
• Yang HS, Choi YJ, Han HY, et al. Serum and aqueous humor adiponectin levels correlate with diabetic retinopathy development and progression. PLoS One. 2021;16(11):e0259683. doi:10.1371/journal.pone.0259683
   PubMed Web of Science ®Google Scholar
• Nigro E, Scudiero O, Monaco ML, et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int. 2014;2014:658913. doi:10.1155/2014/658913
   PubMed Web of Science ®Google Scholar
• Consultation, WHO Expert. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi:10.1016/S0140-6736(03)15268-3
   PubMed Web of Science ®Google Scholar
• Takebe N, Tanno K, Ohmomo H, et al. Weight gain after 20 years of age is associated with unfavorable lifestyle and increased prevalence of metabolic disorders. Diabetes Metab Syndr Obes. 2021;14:2065–2075. doi:10.2147/DMSO.S300250
   PubMed Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682. doi:10.1016/S0161-6420(03)00475-5
   PubMed Web of Science ®Google Scholar
• Araki E, Goto A, Kondo T, et al. Japanese clinical practice guideline for diabetes 2019. Diabetol Int. 2020;11(3):165–223. doi:10.1007/s13340-020-00439-5
   PubMed Web of Science ®Google Scholar
• Hangai M, Takebe N, Honma H, et al. Association of advanced glycation end products with coronary artery calcification in Japanese subjects with type 2 diabetes as assessed by skin autofluorescence. J Atheroscler Thromb. 2016;23(10):1178–1187. doi:10.5551/jat.30155
   PubMed Web of Science ®Google Scholar
• Wei L, Li Y, Yu Y, et al. Obesity-related glomerulopathy: from mechanism to therapeutic target. Diabetes Metab Syndr Obes. 2021;14:4371–4380. doi:10.2147/DMSO.S334199
   PubMed Web of Science ®Google Scholar
• Borges MC, Lawlor DA, de Oliveira C, White J, Horta BL, Barros AJ. Role of adiponectin in coronary heart disease risk: a Mendelian randomization study. Circ Res. 2016;119(3):491–499. doi:10.1161/CIRCRESAHA.116.308716
   PubMed Web of Science ®Google Scholar
• Dieplinger B, Haltmayer M, Poelz W, Mueller T. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study. Clin Chim Acta. 2009;408(1–2):87–91. doi:10.1016/j.cca.2009.07.014
   PubMed Web of Science ®Google Scholar
• Kizer JR, Benkeser D, Arnold AM, et al. Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation. 2012;126(25):2951–2961. doi:10.1161/CIRCULATIONAHA.112.135202
   PubMed Web of Science ®Google Scholar
• Chong DQ, Mehta RS, Song M, et al. Prediagnostic plasma adiponectin and survival among patients with colorectal cancer. Cancer Prevent Res. 2015;8(12):1138–1145. doi:10.1158/1940-6207.CAPR-15-0175
   PubMed Web of Science ®Google Scholar
• Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia. 2005;48(9):1911–1918. doi:10.1007/s00125-005-1850-z
   PubMed Web of Science ®Google Scholar
• Fan X, Wu Q, Li Y, et al. Association between adiponectin concentrations and diabetic retinopathy in patients with type 2 diabetes: a meta analysis. Chin Med J. 2014;127(4):765–771.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Shimomura I, Sata M, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002;277(40):37487–37491. doi:10.1074/jbc.M206083200
   PubMed Web of Science ®Google Scholar
• Aubert CE, Liabeuf S, Amouyal C, et al. Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy. Diabetol Metab Syndr. 2019;11:32. doi:10.1186/s13098-019-0429-7
   PubMed Web of Science ®Google Scholar
• Higuchi A, Ohashi K, Kihara S, Walsh K, Ouchi N. Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression. Circ Res. 2009;104(9):1058–1065. doi:10.1161/CIRCRESAHA.109.194506
   PubMed Web of Science ®Google Scholar
• Bushra S, Al-Sadeq DW, Bari R, Sahara A, Fadel A, Rizk N. Adiponectin ameliorates hyperglycemia-induced retinal endothelial dysfunction, highlighting pathways, regulators, and networks. J Inflamm Res. 2022;15:3135–3166. doi:10.2147/JIR.S358594
   PubMed Web of Science ®Google Scholar
• Fujishima Y, Maeda N, Matsuda K, et al. Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis. FASEB j. 2017;31(4):1571–1583. doi:10.1096/fj.201601064R
   PubMed Web of Science ®Google Scholar
• Sakaue TA, Fujishima Y, Fukushima Y, et al. Adiponectin accumulation in the retinal vascular endothelium and its possible role in preventing early diabetic microvascular damage. Sci Rep. 2022;12(1):4159. doi:10.1038/s41598-022-08041-2
   PubMed Web of Science ®Google Scholar
• Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008;118(5):1645–1656. doi:10.1172/JCI32691
   PubMed Web of Science ®Google Scholar
• Esmaili S, Hemmati M, Karamian M. Physiological role of adiponectin in different tissues: a review. Arch Physiol Biochem. 2020;126(1):67–73. doi:10.1080/13813455.2018.1493606
   PubMed Web of Science ®Google Scholar
• Ma OK, Ronsisvalle S, Basile L, et al. Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathy. Biomed Pharmacother. 2022;158:114141. doi:10.1016/j.biopha.2022.114141
   PubMed Web of Science ®Google Scholar
• Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci. 2019;20(10):2519. doi:10.3390/ijms20102519
   PubMed Web of Science ®Google Scholar
• Maeda N, Takahashi M, Funahashi T, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50(9):2094–2099. doi:10.2337/diabetes.50.9.2094
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Kralisch S, Klier M, et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2003;301(4):1045–1050. doi:10.1016/S0006-291X(03)00090-1
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem. 2001;276(44):41245–41254. doi:10.1074/jbc.M103241200
   PubMed Web of Science ®Google Scholar
• Drolet R, Bélanger C, Fortier M, et al. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Obesity. 2009;17(3):424–430. doi:10.1038/oby.2008.555
   PubMed Web of Science ®Google Scholar
• Van Berendoncks AM, Garnier A, Beckers P, et al. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail. 2010;3(2):185–194. doi:10.1161/CIRCHEARTFAILURE.109.885525
   PubMed Web of Science ®Google Scholar
• Wang Y, Ma XL, Lau WB. Cardiovascular Adiponectin resistance: the critical role of adiponectin receptor modification. Trends Endocrinol Metabol. 2017;28(7):519–530. doi:10.1016/j.tem.2017.03.004
   PubMed Web of Science ®Google Scholar
• Matsuda K, Fujishima Y, Maeda N, et al. Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice. Endocrinology. 2015;156(3):934–946. doi:10.1210/en.2014-1618
   PubMed Web of Science ®Google Scholar
• Obata Y, Yamada Y, Takahi Y, et al. Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetes. Clin Endocrinol. 2013;79(2):204–210. doi:10.1111/cen.12041
   PubMed Web of Science ®Google Scholar